Tumor necrosis factor (TNF)-α has been identified as a key cytokine impacting melanocytic antigens and leading to the failure of adoptive T-cell transfer therapies (ACTs) in the transgenic mouse-derived HCmel3 melanoma cell line [62]. The gene discussed is TNF; the disease is melanoma.